Advanced in Denys-Drash Syndrome (DDS)
Advanced in Denys-Drash Syndrome (DDS)
1275 York Ave, 
New York, NY 

Overview

Christopher Forlenza is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Forlenza is rated as an Advanced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). His top areas of expertise are Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Histiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 13 clinical trials in the study of Denys-Drash Syndrome (DDS).

Specialties
Pediatric Hematology Oncology
Licenses
Student in an Organized Health Care Education/Training Program in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Health First
  • HMO
  • POS
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1275 York Ave, New York, NY 10065

Additional Areas of Focus

Dr. Forlenza has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
View 19 Less Clinical Trials
Similar Doctors
Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
100 Madison Ave, Box 70, 
Morristown, NJ 
 (26.7 miles away)
Languages Spoken:
English

John Gregory is a Pediatric Hematologist Oncology provider in Morristown, New Jersey. Dr. Gregory is rated as an Advanced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). His top areas of expertise are Hepatoblastoma, Langerhans Cell Histiocytosis, Intersex, Denys-Drash Syndrome (DDS), and Bone Marrow Aspiration.

Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
5645 Main St, 
Flushing, NY 
 (6.9 miles away)
Languages Spoken:
English

Alexander Aledo is a Pediatric Hematologist Oncology provider in Flushing, New York. Dr. Aledo is rated as an Advanced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, and Bone Marrow Aspiration.

Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
Advanced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology

North Shore-Lij Medical PC

New Hyde Park, NY 
 (14.5 miles away)
Experience:
16+ years
Languages Spoken:
English

Julie Krystal is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Krystal has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). Her top areas of expertise are Neuroblastoma, Medulloblastoma, Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Forlenza's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile